• 2936 Citations
  • 33 h-Index
1987 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Mark S. Ledoux is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 10 Similar Profiles
Dystonia Medicine & Life Sciences
Dystonic Disorders Medicine & Life Sciences
Parkinson Disease Medicine & Life Sciences
Cerebellum Medicine & Life Sciences
Mutation Medicine & Life Sciences
Torticollis Medicine & Life Sciences
Movement Disorders Medicine & Life Sciences
Brain Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1987 2019

45 Long-term Treatment with Deutetrabenazine Is Associated with Continued Improvement in Tardive Dyskinesia: Results from an Open-label Extension Study

Hauser, R. A., Fernandez, H. H., Stamler, D., Davis, M. D., Factor, S. A., Jimenez-Shahed, J., Ondo, W. G., Jarskog, L. F., Woods, S. W., Ledoux, M., Shprecher, D. R. & Anderson, K. E., Feb 1 2019, In : CNS spectrums. 24, 1, p. 200-201 2 p.

Research output: Contribution to journalArticle

Open Access
Therapeutics
deutetrabenazine
Tardive Dyskinesia
Placebos
Los Angeles

46 Confirmed Safety of Deutetrabenazine for Tardive Dyskinesia in a 2-Year Open-label Extension Study

Fernandez, H. H., Stamler, D., Davis, M. D., Factor, S. A., Hauser, R. A., Jimenez-Shahed, J., Ondo, W. G., Jarskog, L. F., Woods, S. W., Ledoux, M., Shprecher, D. R. & Anderson, K. E., Feb 1 2019, In : CNS spectrums. 24, 1, 1 p.

Research output: Contribution to journalArticle

Open Access
Safety
Placebos
Psychomotor Agitation
Incidence
Suspensions

Long-term safety and efficacy of deutetrabenazine for the treatment of tardive dyskinesia

Fernandez, H. H., Stamler, D., Davis, M. D., Factor, S. A., Hauser, R. A., Jimenez-Shahed, J., Ondo, W. G., Jarskog, L. F., Woods, S. W., Bega, D., Ledoux, M., Shprecher, D. R. & Anderson, K. E., Jan 1 2019, In : Journal of Neurology, Neurosurgery and Psychiatry.

Research output: Contribution to journalArticle

Open Access
Safety
Psychomotor Agitation
Cytochrome P-450 CYP2D6
deutetrabenazine
Tardive Dyskinesia
3 Citations (Scopus)

A recurrent de novo missense mutation in UBTF causes developmental neuroregression

C4RCD Research Group, Feb 15 2018, In : Human molecular genetics. 27, 4, p. 691-705 15 p., ddx435.

Research output: Contribution to journalArticle

Missense Mutation
Transcription Factors
DNA-Directed RNA Polymerases
Exome
Dysarthria

Consequences of Cre-mediated deletion of Ciz1 exon 5 in mice

Xiao, J., Khan, M. M., Vemula, S., Tian, J. & Ledoux, M., Sep 1 2018, In : FEBS Letters. 592, 18, p. 3101-3110 10 p.

Research output: Contribution to journalArticle

Exons
DNA
Cells
Fibroblasts
DNA Damage